Impact of Personalized Medicine On Biochips Market: Pivotal Factor Influencing Biochips Market Growth in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Biochips Market Size Growth Forecast: What to Expect by 2025?
In recent years, the size of the biochips market has seen significant expansion. It is forecasted to rise from $12.62 billion in 2024 to $14.72 billion in 2025, with a compound annual growth rate (CAGR) of 16.6%. The surge during the historic period is due to a variety of factors including increased consumer interest in personalized medicine, the high prevalence of chronic illnesses, technological breakthroughs, wider use in drug discovery, growth in R&D investment, and favorable regulatory policies.

How Will the Biochips Market Size Evolve and Grow by 2029?
Rapid expansion is anticipated in the biochips market over the coming years, with a projected growth to $26.94 billion by 2029, at a compound annual growth rate (CAGR) of 16.3%. This growth within the forecast period is credited to a surge in its use in point-of-care diagnostics, wider applications in drug creation, an increase in demand for bespoke medicine, breakthroughs in microfluidics tech, a rise in research and development investment, and growing partnerships between biotech firms and academic institutions, as well as up-and-coming opportunities in agricultural biotech. Key trends expected in the forecast period involve progress in microfluidics technology, focus on the development of biochips for liquid biopsy uses, surging demand for multiplexed assays that allow for simultaneous detection of various analytes, incorporation of AI for data interpretation, and the arrival of innovative biochip platforms.

View the full report here:
https://www.thebusinessresearchcompany.com/report/biochips-global-market-report

What Drivers Are Propelling the Growth of Biochips Market Forward?
The biochips market's expansion is anticipated to escalate owing to the rising adoption of personalized medicines. Personalized medicine implies modifying a therapeutic approach to fit specific individual traits like genetics or lifestyle, so as to enhance its efficacy and reduce side effects. The increasing demand for such tailored health care is motivated by its promise of more effective treatments, advancements in genomics, escalations in disease complexity, and regulatory support. Biochips facilitate personalized medical care by providing accurate treatment plans customized to an individual's genetic makeup. For example, the US-based non-profit organization, the Personalized Medicine Coalition, reported in February 2024 that the FDA sanctioned 16 unique personalized therapies for patients suffering from rare diseases in 2023, as against six in the previous year. Therefore, the escalating adoption of personalized medicines is spurring the growth of the biochips market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15737&type=smp

Which Emerging Trends Are Transforming the Biochips Market in 2025?
Key players in the biochips market are focused on creating state-of-the-art technologies such as organ-on-a-chip platforms with the aim to transform the procedures of drug discovery and development. These organ-on-a-chip platforms are highly innovative microfluidic devices designed to imitate the physiological properties and operations of human organs in a miniaturized version. Take for instance, Boston Micro Fabrication (BMF), a nanotechnology research firm in the US, unveiled BMF Biotechnology Inc. in April 2024. BMF Biotechnology Inc. dedicates itself to Biochips, also recognized as organ-on-a-chip platforms, that are developed to grow large-scale tissues in vitro. This progress expedites the creation of novel drugs and cosmetics by offering a platform for experimentation and research outside of the human body.

What Are the Key Segments in the Biochips Market?
The biochips market covered in this report is segmented -

1) By Type: Deoxyribonucleic Acid (DNA) Chips, Protein Chips, Lab-On-Chip, Tissue Arrays, Cell Arrays
2) By Technology: Microarrays, Microfluidics
3) By Application: Drug Discovery And Development, Agriculture, Genomics, Disease Diagnostics, Proteomics, Other Applications
4) By End-User: Biotechnology And Pharmaceutical Companies, Academic And Research Institutes, Hospitals And Diagnostic Centers, Other End-Users

Subsegments:
1) By Deoxyribonucleic Acid (Dna) Chips: Gene Expression Chips, Snp (Single Nucleotide Polymorphism) Chips, Dna Microarrays
2) By Protein Chips: Antibody Arrays, Protein Microarrays, Peptide Arrays
3) By Lab-On-Chip: Microfluidic Devices, Biosensors
4) By Tissue Arrays: Tumor Tissue Arrays, Normal Tissue Arrays
5) By Cell Arrays: Cell-Based Biochips, Cell Signaling Arrays

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15737&type=smp

Who Are the Key Players Shaping the Biochips Market's Competitive Landscape?
Major companies operating in the biochips market are Thermo Fisher Scientific Inc., Roche Diagnostics International Ltd., Zoetis Inc., Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Group Ltd., Cepheid Inc., Randox Laboratories Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Luminex Corporation, Fluidigm Corporation, Micronit Microtechnologies B.V., Sphere Fluidics Limited, Sengenics, Arrayit Corporation, CustomArray Inc., Partek Incorporated, NanoCellect Biomedical Inc., Dolomite Microfluidics, Biocartis NV

What Geographic Markets Are Powering Growth in the Biochips Market?
North America was the largest region in the biochips market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biochips market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15737

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.